SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-02-001708
Filing Date
2002-03-28
Accepted
2002-03-28 00:00:00
Documents
6
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 INTERLEUKIN FORM 10-K b42254ige10-k.txt 10-K 199812
3 INTERLEUKIN FORM 10-K b42254ige10-kpdf.pdf 10-K 299517
4 COMMERCIAL LEASE b42254igex10-34.txt EX-10.34 41283
5 SUBSIDIARIES b42254igex21-1.txt EX-21.1 857
6 REPORT OF ARTHUR ANDERSEN b42254igex23-1.txt EX-23.1 2644
7 LETTER TO COMMISSION b42254igex99-1.txt EX-99.1 1362
  Complete submission text file 0000950135-02-001708.txt   547652
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-07
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23413 | Film No.: 02590538
SIC: 2835 In Vitro & In Vivo Diagnostic Substances